Go Pro
NASDAQ:CYRX

CryoPort Q2 2026 Earnings Report

CryoPort logo
$16.17 +0.45 (+2.86%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$16.14 -0.04 (-0.22%)
As of 07/10/2026 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CryoPort EPS Results

Actual EPS
N/A
Consensus EPS
-$0.20
Beat/Miss
N/A
One Year Ago EPS
N/A

CryoPort Revenue Results

Actual Revenue
N/A
Expected Revenue
$48.21 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

CryoPort Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

CryoPort Earnings Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More CryoPort Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CryoPort? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CryoPort and other key companies, straight to your email.

About CryoPort

CryoPort (NASDAQ:CYRX) (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms. These solutions enable uninterrupted maintenance of ultra-low temperatures during transit, while providing customers with transparency and compliance documentation. In addition to specialized containers for liquid nitrogen-based shipments, CryoPort offers on-demand logistics services, temperature excursion management and supply chain optimization tools via its cloud-based CryoPortal platform.

Leveraging a global network of logistics partners, CryoPort delivers services across North America, Europe, Asia-Pacific and Latin America. The company’s 24/7 operations and qualified service centers help streamline regulatory requirements and minimize risk for research institutions, pharmaceutical and biotechnology companies, contract research organizations and cell therapy manufacturers. CryoPort continues to expand its infrastructure and technology offerings to support the growing demand for advanced therapy supply chains worldwide.

View CryoPort Profile